Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Real-time Estimate Tradegate Other stock markets 05:11:25 2026-08-04 am EDT			5-day change	1st Jan Change
58.95 ^EUR	+0.68%		-1.34%	-7.32%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Fundamentals
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.45B	BBB
ELI LILLY AND COMPANY	1T	A
JOHNSON & JOHNSON	613B	BBB
ABBVIE INC.	433B	AA	-
ROCHE HOLDING AG	350B	AA
NOVARTIS AG	292B	AAA
ASTRAZENECA PLC	239B	A
NOVO NORDISK A/S	206B	A
AMGEN INC.	204B	A
GILEAD SCIENCES, INC.	163B	AA
PFIZER INC.	143B	A
BRISTOL-MYERS SQUIBB COMPANY	134B	A
VERTEX PHARMACEUTICALS INCORPORATED	119B	AA
GSK PLC	103B	AA
SANOFI	103B	AA
CHUGAI PHARMACEUTICAL CO., LTD.	70.18B	AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	55.08B	AA
BAYER AG	53.26B	AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	51.77B	AA
HALEON PLC	42.85B	AA
Average	218.92B	AA
Weighted average by Cap.		AA